treprostinil 0.08 MG Inhalation Powder [Tyvaso]

RxCUI: 2697739
RxNorm name: treprostinil 0.08 MG Inhalation Powder [Tyvaso]
Display name: treprostinil 0.08 MG Inhalation Powder [Tyvaso]
Full name: treprostinil 0.08 MG Inhalation Powder [Tyvaso]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tyvaso DPI	TREPROSTINIL	United Therapeutics Corporation	ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	2025-11-20	Warnings, Adverse reactions	Exact identifier rxcui: 2697739

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	treprostinil 0.08 MG Inhalation Powder [Tyvaso]	SBD	14	These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002	20251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	Tyvaso 80 MCG Inhalation Powder	SY	14	These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002	20251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	TYVASO DPI 80 MCG Inhalation Powder	PSN	14	These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002	20251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f	Tyvaso 0.08 MG Inhalation Powder	SY	14	These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002	20251120